Effect of NAD+ boosting on kidney ischemia-reperfusion injury.

Abstract

Acute kidney injury (AKI) is associated with a very high mortality and an increased risk for progression to chronic kidney disease (CKD). Ischemia-reperfusion injury (IRI) is a model for AKI, which results in tubular damage, dysfunction of the mitochondria and autophagy, and in decreased cellular nicotinamide adenine dinucleotide (NAD+) with progressing fibrosis resulting in CKD. NAD+ is a co-enzyme for several proteins, including the NAD+ dependent sirtuins. NAD+ augmentation, e.g. by use of its precursor nicotinamide riboside (NR), improves mitochondrial homeostasis and organismal metabolism in many species. In the present investigation the effects of prophylactic administration of NR on IRI-induced AKI were studied in the rat. Bilateral IRI reduced kidney tissue NAD+, caused tubular damage, reduced α-Klotho (klotho), and altered autophagy flux. AKI initiated progression to CKD, as shown by induced profibrotic Periostin (postn) and Inhibin subunit beta-A, (activin A / Inhba), both 24 hours and 14 days after surgery. NR restored tissue NAD+ to that of the sham group, increased autophagy (reduced p62) and sirtuin1 (Sirt1) but did not ameliorate renal tubular damage and profibrotic genes in the 24 hours and 14 days IRI models. AKI induced NAD+ depletion and impaired autophagy, while augmentation of NAD+ by NR restored tissue NAD+ and increased autophagy, possibly serving as a protective response. However, prophylactic administration of NR did not ameliorate tubular damage of the IRI rats nor rescued the initiation of fibrosis in the long-term AKI to CKD model, which is a pivotal event in CKD pathogenesis.

• Authors: Marya Morevati, Søren Egstrand, Anders Nordholm, Maria L Mace, Claus B Andersen, Rouzbeh Salmani, Klaus Olgaard, Ewa Lewin
• Journal: PloS one (PLoS One) Vol. 16 Issue 6 Pg. e0252554 ( 2021) ISSN: 1932-6203 [Electronic] United States
• PMID: 34061900 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Protective Agents
• Pyridinium Compounds
• nicotinamide-beta-riboside
• NAD
• Niacinamide
• Glucuronidase
• Klotho Proteins
• Sirtuin 1

Topics

• Acute Kidney Injury (complications, drug therapy, etiology, metabolism)
• Animals
• Autophagy (drug effects)
• Disease Progression
• Fibrosis
• Glucuronidase (metabolism)
• Kidney (metabolism, pathology)
• Klotho Proteins
• Male
• Mitochondria (metabolism)
• NAD (metabolism)
• Niacinamide (administration & dosage, analogs & derivatives)
• Protective Agents (administration & dosage)
• Pyridinium Compounds (administration & dosage)
• Random Allocation
• Rats
• Rats, Wistar
• Renal Insufficiency, Chronic (etiology)
• Reperfusion Injury (complications, metabolism)
• Signal Transduction (drug effects)
• Sirtuin 1 (metabolism)
• Treatment Outcome